Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Lurasidone

An atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors. Approved in the United States in 2010 for schizophrenia and in 2013 for depression associated with bipolar disorder. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Among second-generation antipsychotics it has the highest affinity for the serotonin 5-HT7 receptor, which is involved in regulating mood, sleep, circadian rhythms and memory.

LurasidoneGo to the active ingredient →
LurasidoneActive ingredientLurasidoneCat. No. P-L110-001CAS 367514-87-2
Lurasidone-d8Isotopically labelledLurasidone-d8Cat. No. P-L110-011CAS 1132654-54-6
CanthareneImpurityCanthareneCat. No. P-L110-030CAS 4430-91-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.